[View original text]

On 13th of October, AIDOT announced that it has completed the patent registration of the ‘automatic cervical cancer diagnosis system’ related to its cervical cancer artificial 

intelligence diagnosis system (Cerviray).

This solution includes criteria for classifying malignant atypical blood vessel patterns, and a patent has been registered for this part.

The artificial intelligence solution in question has become visible not only in Southeast Asia but also in Russia, and full-fledged entry through joint ventures is being promoted in North America.

AIDOT's CEO Jae-hoon Jeong said, "As the validity and business feasibility of Cerviray, a cervical cancer AI solution, is confirmed and proven in the global market, latecomers and copy operators are expected to gradually emerge, so the patent registration will strengthen differentiation from global competitors and speed entry into major individual countries through 

global patent applications."

13th. Oct. 2021. / Korea Economy TV